Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug safety funds

Executive Summary

Drug safety oversight would have funding of $40 million under an amendment Senate Health Committee Chairman Ted Kennedy, D-Mass., successfully proposed to the Senate budget plan March 23. The resolution outlines a budget blueprint for congressional appropriations. Kennedy and committee ranking Republican Michael Enzi, Wyo., cosponsored the most prominent pending drug safety bill in the Senate, S 484 (1"The Pink Sheet" March 26, 2007, p. 4). The Senate cleared its budget plan March 23 and the House passed its version March 29; a conference committee will resolve differences between the two bills after the mid-April congressional recess...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel